AzTrials
AzTrials

Virtual PatientDebriefingNCT06677398

Three Debriefing Methods in Virtual Patient Simulation

A study testing Debriefing Method 1, Debriefing Method VP and Debriefing Method 2 in people with Virtual Patient and Debriefing Method, run by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In simulation-based training, the debriefing session is considered a cornerstone of learning. Therefore, this study aims to compare two different methods of debriefing sessions. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
Debriefing Method 1, Debriefing Method VP and Debriefing Method 2
Could I receive a placebo?
No, everyone receives an active treatment
How many people
109 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Nov 2024to 29 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Being 4th grade nursing student at a nursing faculty

Who cannot join

  • Not having participated in simulation before and not having practiced with a virtual patient.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • University of Health Sciences Turkey, Gulhane Faculty of Nursing

    Ankara, Etlik

Other trials in Turkey (Türkiye)

About this study

Official title: Three Debriefing Methods in Virtual Patient Simulation: A Randomized Controlled Trial

In simulation-based training, the debriefing session is considered a cornerstone of learning. Therefore, this study aims to compare two different methods of debriefing sessions.

Being tested
Debriefing Method 1, Debriefing Method VP, Debriefing Method 2
Keywords
Debriefing, Feedback, Effectiveness, Patient Simulation, Virtual Systems, Nursing Students

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Debriefing Method 1Other

    The researchers used a debriefing method that they chose after a virtual simulation

  • Debriefing Method VPOther

    The researchers used the debriefing method that virtual patient simulator presents

  • Debriefing Method 2Other

    The researchers used a debriefing method that they chose after a virtual simulation

Study groups in NCT06677398
Study groupRoleWhat they receive
Group AExperimentalExperimental group that used one of the debriefing methods
Receives: Other: Debriefing Method 1
Group BExperimentalExperimental group that used one of the debriefing methods
Receives: Other: Debriefing Method 2
Group COtherA control group that used none of the debriefing methods
Receives: Other: Debriefing Method VP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hypothesis 1

    There is a difference in the Simulation Effectiveness Tool scores between students using debriefing methods.

    Measured: 1 week

  2. Hypothesis 2

    There is a difference in the Debriefing Experience Scale scores between students using debriefing methods.

    Measured: 1 week

  3. Hypothesis 3

    There is a difference in The Student Satisfaction and Self-confidence scores between students using debriefing methods.

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2024
  2. Study start1 Nov 2024
  3. Primary completion29 Jan 2025
  4. Study completion29 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel group-randomized trial
Masking
Single blind
Who is masked
Participant
Enrolment
109 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06677398
Sponsor's protocol ID
Date: 10.09.2024 No:2024-435
Acronym
Debriefing
Status last verified
Feb 2025
First submitted
2 Nov 2024
Last updated
11 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Researchers believe that it is important to share the data of the study with other researchers following the completion of the data.

Publications

  • Dreifuerst, K.T., 2015. Getting started with debriefing for meaningful learning. Clin Simul Nurs 11, 268-275. https://doi.org/10.1016/j.ecns.2015.01.005

  • Decker, S., Alinier, G., Crawford, S.B., Gordon, R.M., Jenkins, D., Wilson, C., 2021. Healthcare Simulation Standards of Best PracticeTM The Debriefing Process. Clin Simul Nurs 58, 27-32. https://doi.org/10.1016/j.ecns.2021.08.011

  • Cheng A, Kessler D, Mackinnon R, Chang TP, Nadkarni VM, Hunt EA, Duval-Arnould J, Lin Y, Cook DA, Pusic M, Hui J, Moher D, Egger M, Auerbach M; International Network for Simulation-based Pediatric Innovation, Research, and Education (INSPIRE) Reporting Guidelines Investigators. Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements. Adv Simul (Lond). 2016 Jul 25;1:25. doi: 10.1186/s41077-016-0025-y. eCollection 2016.

    PubMed 29449994

Questions about this trial

What is this clinical trial studying?

A study testing Debriefing Method 1, Debriefing Method VP and Debriefing Method 2 in people with Virtual Patient and Debriefing Method, run by Saglik Bilimleri Universitesi Gulhane Tip Fakultesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hypothesis 1 (time frame: 1 week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06677398, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in